Laurus Labs Q2 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
1,047.00
16.75 (1.63%)
16.75 (1.63%)Volume38.82 K
Updated: Thu 5 Mar, 2026 | 15:29:15
NSE
1,045.9015.30 (1.48%)
15.30 (1.48%)Volume9.38 L
Updated: Thu 5 Mar, 2026 | 15:50:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Laurus Labs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,370.70 | 1,304.28 | 5.09% | 1,152.88 | 18.89% |
| Depreciation/ Amortization | 120.49 | 116.84 | 3.12% | 107.51 | 12.07% |
| Operating Income | 282.77 | 265.29 | 6.59% | 70.82 | 299.28% |
| Net Income | 194.97 | 163.02 | 19.60% | 19.84 | 882.71% |
| Other Operating Expenses Total | 371.21 | 335.29 | 10.71% | 318.35 | 16.60% |
| Net Income Before Taxes | 269.73 | 224.22 | 20.30% | 22.81 | 1082.51% |
| Total Revenue | 1,653.47 | 1,569.57 | 5.35% | 1,223.70 | 35.12% |
| Selling/ General/ Admin Expenses Total | 215.56 | 214.80 | 0.35% | 178.72 | 20.61% |
| Diluted Normalized EPS | 3.61 | 3.02 | 19.54% | 0.37 | 875.68% |